These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6743483)

  • 1. Pharmacokinetics of cyclophosphamide in Kenyan African children with lymphoma.
    Juma FD; Koech DK; Kasili EG; Ogada T
    Br J Clin Pharmacol; 1984 Jul; 18(1):106-7. PubMed ID: 6743483
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of cyclophosphamide in Kenyan Africans.
    Juma F; Ogada T
    Br J Clin Pharmacol; 1983 Jul; 16(1):61-3. PubMed ID: 6882623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP).
    Traoré F; Coze C; Atteby JJ; André N; Moreira C; Doumbe P; Ravelomanana N; Ye D; Patte C; Raquin MA; Raphael M; Lemerle J
    Pediatr Blood Cancer; 2011 Jan; 56(1):70-6. PubMed ID: 21058286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group.
    McCune JS; Salinger DH; Vicini P; Oglesby C; Blough DK; Park JR
    J Clin Pharmacol; 2009 Jan; 49(1):88-102. PubMed ID: 18927240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenobarbital effects on cyclophosphamide pharmacokinetics in man.
    Jao JY; Jusko WJ; Cohen JL
    Cancer Res; 1972 Dec; 32(12):2761-4. PubMed ID: 4678592
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution and pharmacokinetics of cyclophosphamide in the rat.
    Talha MR; Rogers HJ; Trounce JR
    Br J Cancer; 1980 Jan; 41(1):140-3. PubMed ID: 7362775
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma.
    Veal GJ; Cole M; Chinnaswamy G; Sludden J; Jamieson D; Errington J; Malik G; Hill CR; Chamberlain T; Boddy AV
    Eur J Cancer; 2016 Mar; 55():56-64. PubMed ID: 26773420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetics of salivary elimination of cyclophosphamide in man.
    Juma FD; Rogers HJ; Trounce JR
    Br J Clin Pharmacol; 1979 Nov; 8(5):455-8. PubMed ID: 508550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the pharmacokinetics of cyclophosphamide in sheep.
    Schaumlöffel E; Habermehl A; Brock N; Schneider B
    Arzneimittelforschung; 1973 Apr; 23(4):491-500. PubMed ID: 4740226
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclophosphamide metabolism in children.
    Yule SM; Boddy AV; Cole M; Price L; Wyllie R; Tasso MJ; Pearson AD; Idle JR
    Cancer Res; 1995 Feb; 55(4):803-9. PubMed ID: 7850793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.
    Juma FD; Rogers HJ; Trounce JR
    Br J Clin Pharmacol; 1979 Sep; 8(3):209-17. PubMed ID: 497087
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of damaged liver parenchyma, renal insufficiency and hemodialysis on the pharmacokinetics of cyclophosphamide and its activated metabolites].
    Wagner T; Heydrich D; Bartels H; Hohorst HJ
    Arzneimittelforschung; 1980; 30(9):1588-92. PubMed ID: 7193030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of cyclophosphamide.
    Grochow LB; Colvin M
    Clin Pharmacokinet; 1979; 4(5):380-94. PubMed ID: 389529
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patients.
    D'Incalci M; Facchinetti T; Bolis G; Mangioni C; Morasca L
    Eur J Drug Metab Pharmacokinet; 1979; 4(2):83-5. PubMed ID: 114397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients.
    Nakajima M; Komagata S; Fujiki Y; Kanada Y; Ebi H; Itoh K; Mukai H; Yokoi T; Minami H
    Pharmacogenet Genomics; 2007 Jun; 17(6):431-45. PubMed ID: 17502835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLasma half-life and urinary excretion of cyclophosphamide in children.
    Sladek NE; Priest J; Doeden D; Mirocha CJ; Pathre S; Krivit W
    Cancer Treat Rep; 1980; 64(10-11):1061-6. PubMed ID: 7459891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methylation status in promoter region of runx3 gene on cases of children malignant lymphoma and its dynamic].
    Meng JH; Diao YQ; Yang MJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):954-6. PubMed ID: 23363756
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary therapeutic results of treatment of non-Hodgkin lymphoma in children according to the BACOP program].
    Bogusławska-Jaworska J; Grześkowiak-Melanowska J; Kaczmarek M; Kościelniak E; Legutko L; Sońta-Jakimczyk D; Sroczyńska M; Wojcik Z
    Pediatr Pol; 1980 Feb; 55(2):207-10. PubMed ID: 6154919
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of anticancer drugs in children.
    Evans WE; Crom WR; Sinkule JA; Yee GC; Stewart CF; Hutson PR
    Drug Metab Rev; 1983; 14(5):847-86. PubMed ID: 6197269
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy.
    Kazembe P; Hesseling PB; Griffin BE; Lampert I; Wessels G
    Med Pediatr Oncol; 2003 Jan; 40(1):23-5. PubMed ID: 12426682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.